SEARCH

SEARCH BY CITATION

References

  • 1
    Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257267.
  • 2
    von Harsdorf R, Li PF, Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999; 99: 29342941.
  • 3
    Tanaka Y, Gleason CE, Tran PO, et al. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 1999; 96: 10 85710 862.
  • 4
    Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res 2000; 87: 11231132.
  • 5
    Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001; 281: E924E930.
  • 6
    Quagliaro L, Piconi L, Assaloni R,et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52: 27952804.
  • 7
    Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787790.
  • 8
    Jaffe EA, Nachman RL, Becker CG, et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 27452756.
  • 9
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977986.
  • 10
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837853.
  • 11
    Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813820.
  • 12
    Ceriello A. Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia. Am Heart J 2004; 147: 803807.
  • 13
    Singleton JR, Smith AG, Russell JW, et al. Microvascular complications of impaired glucose tolerance. Diabetes 2003; 52: 28672873.
  • 14
    Ceriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med 1998; 15: 188193.
    Direct Link:
  • 15
    Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med 1997; 14(Suppl 3): S45S49.
  • 16
    Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003; 35: 14911499.
  • 17
    Kiritoshi S, Nishikawa T, Sonoda K, et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 2003; 52: 25702577.
  • 18
    Krauss S, Zhang CY, Scorrano L, et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 2003; 112: 18311842.
  • 19
    Takeuchi A, Throckmorton DC, Brogden AP, et al. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am J Physiol 1995; 268: F13F19.
  • 20
    Polhill TS, Saad S, Poronnik P, et al. Short-term peaks in glucose promote renal fibrogenesis independent of total glucose exposure. Am J Physiol Renal Physiol 2004; 287: F268F273.
  • 21
    Jones SC, Saunders HJ, Qi W, et al. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia 1999; 42: 11131119.
  • 22
    Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005; 19: 178181.
  • 23
    Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005; 54: 17.
  • 24
    Ceriello A, Morocutti A, Mercuri F, et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000; 49: 21702177.
  • 25
    Kesavulu MM, Giri R, Kameswara Rao B, et al. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 2000; 26: 387392.
  • 26
    Carmeli E, Coleman R, Berner YN. Activities of antioxidant scavenger enzymes (superoxide dismutase and glutathione peroxidase) in erythrocytes in adult women with and without type II diabetes. Exp Diabesity Res 2004; 5: 171175.
  • 27
    Ihnat MA, Green DW, Ross K, et al. Reduced antioxidant Response of retinal and endothelial cells in response to cronic oscillating glucose levels. Diabetes 2005; 52: A557.
  • 28
    Ceriello A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 2003; 26: 15891596.